UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Adjuvant chemotherapy in non-small cell lung cancer: state-of-the-art

Translational lung cancer research, 2015-04, Vol.4 (2), p.191-197

2015

Volltextzugriff (PDF)

External Beam Radiation Therapy for Palliation of Symptomatic Bone Metastases: An ASTRO Clinical Practice Guideline

Practical Radiation Oncology, 2024-09, Vol.14 (5), p.377-397

2024

Volltextzugriff (PDF)

SEOM clinical guidelines for the treatment of small-cell lung cancer

Clinical & translational oncology, 2010, Vol.12 (1), p.27-31

2010

Volltextzugriff (PDF)

Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial

The Lancet (British edition), 2016-04, Vol.387 (10030), p.1837-1846

2016

Volltextzugriff (PDF)

Opening Windows for Thymic Tumors

Journal of thoracic oncology, 2023-02, Vol.18 (2), p.136-138

2023

Volltextzugriff (PDF)

Nuevas dianas terapéuticas para el carcinoma de células renales metastásico. Resultados del tratamiento con bevacizumab en monoterapia en un único centro hospitalario

Actas urologicas españolas, 2009, Vol.33 (2), p.138-142

2009

Volltextzugriff (PDF)

Lung cancer screening

Revisiones en cáncer, 2023

2023

Volltextzugriff (PDF)

Lung immune prognostic index (LIPI) as a prognostic factor in patients with extensive-stage small cell lung cancer treated with first-line chemoimmunotherapy

Clinical & translational oncology, 2024-09

2024

Volltextzugriff (PDF)

Massive Hemoptysis after the First Administration of Pembrolizumab in a Strongly Positive, Centrally Located NSCLC

Journal of thoracic oncology, 2018-05, Vol.13 (5), p.e76-e77

2018

Volltextzugriff (PDF)

Evidencia de afatinib en pacientes que progresan a un tratamiento de primera línea

Medicina clínica, 2016-04, Vol.146, p.19-24

2016

Volltextzugriff (PDF)

Patterns of Progression and Feasibility of Re-biopsy After First-line Erlotinib for Advanced EGFR Mutation-positive Non-small-cell Lung Cancer

Anticancer research, 2019-03, Vol.39 (3), p.1317-1328

2019

Volltextzugriff (PDF)

Evidence on afatinib in patients progressing on a first-line treatment

Medicina clinica, 2016-04, Vol.146 Suppl 1, p.19

2016

Volltextzugriff (PDF)

Retrospective study of efficacy and toxicity on patients older than 70 years within a randomized clinical trial of two cisplatin-based combinations in patients with small-cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2009-01, Vol.63 (1), p.83-87

2009

Volltextzugriff (PDF)

Heparinas de bajo peso molecular en la profilaxis de episodios tromboembólicos en pacientes con cáncer portadores de catéter venoso central

Medicina clínica, 2009-09, Vol.133 (10), p.365-370

2009

Volltextzugriff (PDF)

Role of low molecular weight heparins in prophylaxis of thromboembolic events on oncological patients with indwelling central venous catheter

Medicina clínica, 2009-09, Vol.133 (10), p.365-370

2009

Volltextzugriff (PDF)

Nuevas dianas terapéuticas para el carcinoma de células renales metastásico: Resultados del tratamiento con bevacizumab en monoterapia en un único centro hospitalario

Actas urologicas españolas, 2009-02, Vol.33 (2)

2009

Volltextzugriff (PDF)

Serum markers and prognosis in locally advanced breast cancer

Tumori, 2005-11, Vol.91 (6), p.522-530

2005

Volltextzugriff (PDF)

Novel therapeutic targets in metastatic renal cell carcinoma. Results of the treatment with single-agent bevacizumab in a single institution

Actas urologicas españolas, 2009-02, Vol.33 (2), p.138-142

2009

Volltextzugriff (PDF)

Increasing-dose gemcitabine plus low-dose cisplatin in metastatic non-small cell lung cancer

Anti-cancer drugs, 2003-02, Vol.14 (2), p.111-118

2003

Volltextzugriff (PDF)

Final results of RENO study: Randomized phase II of oral vinorelbine or etoposide with cisplatin and chemo-radiation in stage III NSCLC. SLCG 10/02

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e20521-e20521

2018

Volltextzugriff (PDF)

Prospective randomized phase III trial of etoposide/cisplatin versus high-dose epirubicin/cisplatin in small-cell lung cancer

Clinical lung cancer, 2004-11, Vol.6 (3), p.175-183

2004

Volltextzugriff (PDF)

Non-classical response measured by immune-modified RECIST and post-progression treatment effects of atezolizumab in 2L/3L NSCLC: Results from the randomized phase II study POPLAR

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.9032-9032

2016

Volltextzugriff (PDF)

Randomized phase II trial (RENO): Efficacy results of oral vinorelbine or etoposide combined with cisplatin in chemo-radiotherapy treatment of locally advanced NSCLC (LA-NSCLC)—SLCG 10/02

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.8538-8538

2016

Volltextzugriff (PDF)

A scalp cooling system designed to prevent chemotherapy-induced alopecia: Our experience with implementation at a Spanish public hospital

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e21660-e21660

2016

Volltextzugriff (PDF)

1 – 25 von 32

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(31)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Adjuvant chemotherapy in non-small cell lung cancer: state-of-the-art

External Beam Radiation Therapy for Palliation of Symptomatic Bone Metastases: An ASTRO Clinical Practice Guideline

SEOM clinical guidelines for the treatment of small-cell lung cancer

Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial

Opening Windows for Thymic Tumors

Nuevas dianas terapéuticas para el carcinoma de células renales metastásico. Resultados del tratamiento con bevacizumab en monoterapia en un único centro hospitalario

Lung cancer screening

Lung immune prognostic index (LIPI) as a prognostic factor in patients with extensive-stage small cell lung cancer treated with first-line chemoimmunotherapy

Massive Hemoptysis after the First Administration of Pembrolizumab in a Strongly Positive, Centrally Located NSCLC

Evidencia de afatinib en pacientes que progresan a un tratamiento de primera línea

Patterns of Progression and Feasibility of Re-biopsy After First-line Erlotinib for Advanced EGFR Mutation-positive Non-small-cell Lung Cancer

Evidence on afatinib in patients progressing on a first-line treatment

Retrospective study of efficacy and toxicity on patients older than 70 years within a randomized clinical trial of two cisplatin-based combinations in patients with small-cell lung cancer

Heparinas de bajo peso molecular en la profilaxis de episodios tromboembólicos en pacientes con cáncer portadores de catéter venoso central

Role of low molecular weight heparins in prophylaxis of thromboembolic events on oncological patients with indwelling central venous catheter

Nuevas dianas terapéuticas para el carcinoma de células renales metastásico: Resultados del tratamiento con bevacizumab en monoterapia en un único centro hospitalario

Serum markers and prognosis in locally advanced breast cancer

Novel therapeutic targets in metastatic renal cell carcinoma. Results of the treatment with single-agent bevacizumab in a single institution

Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB–IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial

Increasing-dose gemcitabine plus low-dose cisplatin in metastatic non-small cell lung cancer

Final results of RENO study: Randomized phase II of oral vinorelbine or etoposide with cisplatin and chemo-radiation in stage III NSCLC. SLCG 10/02

Prospective randomized phase III trial of etoposide/cisplatin versus high-dose epirubicin/cisplatin in small-cell lung cancer

Non-classical response measured by immune-modified RECIST and post-progression treatment effects of atezolizumab in 2L/3L NSCLC: Results from the randomized phase II study POPLAR

Randomized phase II trial (RENO): Efficacy results of oral vinorelbine or etoposide combined with cisplatin in chemo-radiotherapy treatment of locally advanced NSCLC (LA-NSCLC)—SLCG 10/02

A scalp cooling system designed to prevent chemotherapy-induced alopecia: Our experience with implementation at a Spanish public hospital

Suchergebnisse filtern